Balanced news tone
News Sentiment
MYGN sentiment intelligence
Myriad Genetics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
45 relevant articles
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+4.8% over one week, +18.8% over four weeks, trend inactive, and below fair value.
Myriad Genetics Inc (MYGN) Dividends & Stock Splits: Historical Payouts and Event Timeline
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
83/100 classification
One-week reaction
4.8%
Price confirming higher
Trend fit
Trend inactive
18.8% over four weeks
Fair value
-67.4%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
10
Neutral
29
Negative
6
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
Myriad Genetics Inc. (MYGN): Larry Robbins Likes This Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Myriad Genetics in record sell-off after Q1 miss
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Seeking Alpha
simplywall.st
Direct company coverage
Myriad Genetics (MYGN) Q1 Loss Of US$34.1 Million Reinforces Bearish Profitability Concerns
- Tone
- Negative 18/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Myriad Genetics (NASDAQ:MYGN) Misses Q1 CY2026 Sales Expectations, Stock Drops 16.2%
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- Market source
IndexBox
Direct company coverage
Small-Cap Stocks: Krispy Kreme, Myriad Genetics, and Hamilton Insurance Group to Avoid - News and Statistics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Apr 2026 07:00
- Source
- IndexBox
IndexBox
Direct company coverage
Myriad Genetics Q4 2025 Results: Revenue Beat, Raised Guidance - News and Statistics
- Tone
- Positive 84/100
- Event
- Guidance
- Published
- 07 Apr 2026 07:00
- Source
- IndexBox
Market source
Direct company coverage
Myriad Genetics And 2 Other Penny Stocks To Watch Closely
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Mar 2026 08:00
- Source
- Market source
Quiver Quantitative
Direct company coverage
Myriad Genetics (MYGN) Stock Falls on Q4 2025 Earnings
- Tone
- Negative 22/100
- Event
- Earnings
- Published
- 23 Feb 2026 08:00
- Source
- Quiver Quantitative
simplywall.st
Direct company coverage
Little Excitement Around Myriad Genetics, Inc.'s (NASDAQ:MYGN) Revenues As Shares Take 27% Pounding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Feb 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Why Analysts See The Myriad Genetics (MYGN) Story Shifting After The New $7 Target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 05 Feb 2026 08:00
- Source
- Market source
simplywall.st
Direct company coverage
Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Jan 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Why Myriad Genetics (MYGN) Stock Is Down Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Nov 2025 08:00
- Source
- Market source